Literature DB >> 5014610

The development of macrophages from large mononuclear cells in the blood of patients with inflammatory disease.

D A Horwitz.   

Abstract

The origin and function of the increased of "atypical lymphocytes" which appear in the blood of patients with many inflammatory diseases is not known. Leukocyte suspensions from eight patients with systemic lupus erythematosus (SLE), five patients with other rheumatic diseases, and five patients with infectious diseases were pulse-labeled with tritiated thymidine (Tdr-(3)H) and sampled after 5 and 72 hr in vitro. Radioautographs indicated that 35% of the total large, nonphagocytic mononuclear leukocytes incorporated Tdr-(3)H during the initial 5 hr of culture. Tdr-(3)H-labeled large phagocytic or glass-adherent cells were observed only infrequently. After 72 hr one-third of the original number of Tdr-(3)H-labeled cells from patients with SLE developed the morphology of macrophages and the capacity to phagocytose latex particles. Similar findings were observed in patients with other rheumatic diseases and bacterial infections. In contrast, the thymidine-labeled cells from patients with infectious hepatitis and infectious mononucleosis were poorly viable in culture and rarely became macrophages. Tdr-(3)H-labeled small lymphocytes were uncommon. The present experiments suggest that in patients with certain inflammatory diseases large, proliferating "lymphocytelike" cells are very immature monocyte precursors which appear in response to tissue injury. These DNA-synthesizing cells together with mature monocytes may serve as the circulating source of macrophages.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5014610      PMCID: PMC302188          DOI: 10.1172/JCI106870

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  The assessment of stress in human subjects by means of quantitative and qualitative changes of blood lymphocytes.

Authors:  J A FRANK; T F DOUGHERTY
Journal:  J Lab Clin Med       Date:  1953-10

2.  DNA synthesis in circulating blood leukocytes labeled in vitro with H3-thymidine.

Authors:  J R RUBINI; V P BOND; S KELLER; T M FLIEDNER; E P CRONKITE
Journal:  J Lab Clin Med       Date:  1961-11

3.  Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease.

Authors:  D A Horwitz; P Stastny; M Ziff
Journal:  J Lab Clin Med       Date:  1970-09

Review 4.  The atypical lymphocyte.

Authors:  T A Wood; E P Frenkel
Journal:  Am J Med       Date:  1967-06       Impact factor: 4.965

5.  The origins, kinetics, and fate of macrophage populations.

Authors:  B Roser
Journal:  J Reticuloendothel Soc       Date:  1970-08

Review 6.  Origin and kinetics of monocytes and macrophages.

Authors:  R van Furth
Journal:  Semin Hematol       Date:  1970-04       Impact factor: 3.851

7.  The lymphocyte in guinea-pig bone marrow.

Authors:  J M Yoffey; G Hudson; D G Osmond
Journal:  J Anat       Date:  1965-10       Impact factor: 2.610

8.  The kinetics of promonocytes and monocytes in the bone marrow.

Authors:  R van Furth; M M Diesselhoff-Den Dulk
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

9.  The origin and kinetics of mononuclear phagocytes.

Authors:  R van Furth; Z A Cohn
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

10.  The in vitro differentiation of mast cells. Cultures of cells from immunized mouse lymph nodes and thoracic duct lymph on fibroblast monolayers.

Authors:  H Ginsburg; D Lagunoff
Journal:  J Cell Biol       Date:  1967-12       Impact factor: 10.539

View more
  11 in total

1.  Identification of human mononuclear leucocyte populations by esterase staining.

Authors:  D A Horwitz; A C Allison; P Ward; N Kight
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

2.  Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.

Authors:  D A Horwitz; M A Garrett
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

3.  Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin.

Authors:  D A Horwitz; P I Lobo
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

4.  Heredofamilial deficiency of monocyte esterase in patients with rheumatoid arthritis.

Authors:  A L Bell; G M Markey; M D McCaigue; D Middleton; J A McCormick; A G Wilson; T C Morris
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

5.  Hyperbasophilic immunoblasts in circulating blood in chronic inflammatory rheumatic and collagen diseases.

Authors:  F Delbarre; A Le Gô; A Kahan
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

6.  Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes.

Authors:  N P Hurst; G Nuki; T Wallington
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

7.  Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis.

Authors:  N P Hurst; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-27

8.  Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis.

Authors:  Chrystal M Paulos; Bindu Varghese; William R Widmer; Gert J Breur; Erina Vlashi; Philip S Low
Journal:  Arthritis Res Ther       Date:  2006-04-28       Impact factor: 5.156

9.  Neutral protease secretion by human monocytes. Effect of surface-bound immune complexes.

Authors:  C G Ragsdale; W P Arend
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

10.  Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection.

Authors:  S B Halstead; E J O'Rourke; A C Allison
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.